José González‐Campos

Treatment of High-Risk Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia in Adolescents and Adults According to Early Cytologic Response and Minimal Residual Disease After Consolidation Assessed by Flow Cytometry: Final Results of the PETHEMA ALL-AR-03 Trial

Josep‐María Ribera, Albert Oriol, Mireia Morgades et al. · Journal of Clinical Oncology · 2014 · 251 citations · Full text

Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial

Manuela Aguilar‐Guisado, Ildefonso Espigado, Almudena Martín‐Peña et al. · The Lancet Haematology · 2017 · 230 citations

Antibiotics, Antimicrobial Stewardship, Phase 4 +9

Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome–negative adult lymphoblastic leukemia

Josep‐María Ribera, Mireia Morgades, Juana Ciudad et al. · Blood · 2020 · 80 citations · Full text

Dose‐intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status

Josep‐María Ribera, Olga García, Carlos Grande et al. · Cancer · 2013 · 69 citations · Full text

Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy

Eva Barragán, Pau Montesinos, Mireia Camós et al. · Haematologica · 2011 · 63 citations · Full text